Case Brabham
YOU?
Author Swipe
View article: Medical Education Column, Creating a High-Yield Guide to Lifestyle Medicine for Medical Students and Healthcare Professionals
Medical Education Column, Creating a High-Yield Guide to Lifestyle Medicine for Medical Students and Healthcare Professionals Open
Despite their inclusion as first-line therapy for many chronic diseases, lifestyle interventions are often de-emphasized in medical education and fail to make it into the repertoire of non-lifestyle medicine trained clinicians. We sought t…
View article: Table S1 from Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i>: Insights from a Large Neoadjuvant Endocrine Therapy Cohort
Table S1 from Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i>: Insights from a Large Neoadjuvant Endocrine Therapy Cohort Open
Supplementary Table 1
View article: Data from Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i>: Insights from a Large Neoadjuvant Endocrine Therapy Cohort
Data from Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i>: Insights from a Large Neoadjuvant Endocrine Therapy Cohort Open
Ductal carcinoma in situ (DCIS) is a biologically heterogenous entity with uncertain risk for invasive ductal carcinoma (IDC) development. Standard treatment is surgical resection often followed by radiation. New approaches are needed to r…
View article: Data from Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i>: Insights from a Large Neoadjuvant Endocrine Therapy Cohort
Data from Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i>: Insights from a Large Neoadjuvant Endocrine Therapy Cohort Open
Ductal carcinoma in situ (DCIS) is a biologically heterogenous entity with uncertain risk for invasive ductal carcinoma (IDC) development. Standard treatment is surgical resection often followed by radiation. New approaches are needed to r…
View article: Table S2 from Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i>: Insights from a Large Neoadjuvant Endocrine Therapy Cohort
Table S2 from Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i>: Insights from a Large Neoadjuvant Endocrine Therapy Cohort Open
Supplementary Table 2
View article: Table S2 from Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i>: Insights from a Large Neoadjuvant Endocrine Therapy Cohort
Table S2 from Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i>: Insights from a Large Neoadjuvant Endocrine Therapy Cohort Open
Supplementary Table 2
View article: Table S1 from Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i>: Insights from a Large Neoadjuvant Endocrine Therapy Cohort
Table S1 from Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i>: Insights from a Large Neoadjuvant Endocrine Therapy Cohort Open
Supplementary Table 1
View article: Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i> : Insights from a Large Neoadjuvant Endocrine Therapy Cohort
Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i> : Insights from a Large Neoadjuvant Endocrine Therapy Cohort Open
Ductal carcinoma in situ (DCIS) is a biologically heterogenous entity with uncertain risk for invasive ductal carcinoma (IDC) development. Standard treatment is surgical resection often followed by radiation. New approaches are needed to r…
View article: Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma
Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma Open
Neoadjuvant therapy in breast cancer can downstage axillary lymph nodes and reduce extent of axillary surgery. As such, accurate determination of nodal status after neoadjuvant therapy and before surgery impacts surgical management. There …
View article: Legg-Calvé-Perthes Disease Produces Chronic Hip Synovitis and Elevation of Interleukin-6 in the Synovial Fluid
Legg-Calvé-Perthes Disease Produces Chronic Hip Synovitis and Elevation of Interleukin-6 in the Synovial Fluid Open
Legg-Calvé-Perthes disease (LCPD) is a childhood hip disorder of ischemic osteonecrosis of the femoral head. Hip joint synovitis is a common feature of LCPD, but the nature and pathophysiology of the synovitis remain unknown. The purpose o…